The CIN model included sequential injections of indomethacin, L-NAME, and iopromide.EGCG was tested alone for its protective effects.ZnPP was used as an inhibitor to assess the role of HO-1 in the protective mechanisms. The gene discussed is HMOX1; the disease is cervical squamous intraepithelial neoplasia.